Research indicates that TGF-β signaling in tumor cells and their microenvironment enhances tumor immune evasion by promoting PD-L1 expression, recruiting immune-suppressive macrophages, and regulating T cells (Tregs) [72]. This evidence concerns the gene TGFB1 and neoplasm.